Bioventus Inc. 10-Q filing
Filed 2025-11-04 · Report date 2025-09-27 · 2025
Filing metadata
- Accession number
- 0001665988-25-000026
- Form type
- 10-Q
- CIK
- 0001665988
- Primary document
- https://www.sec.gov/Archives/edgar/data/1665988/000166598825000026/bvs-20250927.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Bioventus Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $410.2M | - | - |
| Cost Of Revenue | $130.8M | - | - |
| Gross Profit | $279.4M | - | - |
| Operating Income | $34.5M | - | - |
| Net Income | $8.0M | - | - |
| Eps Basic | 0.12 | - | - |
| Eps Diluted | 0.12 | - | - |
| Cash And Equivalents | $42.2M | - | - |
| Total Assets | $701.6M | - | - |
| Total Liabilities | $494.3M | - | - |
| Shareholders Equity | $166.1M | - | - |
| Operating Cash Flow | $36.7M | - | - |
| Capital Expenditures | $2.0M | - | - |